Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21)

The summary for the Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21): - The National Cancer Institute (NCI), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Biomedical Imaging and Biotechnology (NIBIB), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) are interested in receiving grant applications that address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC) and development of animal models, novel approaches to prevent this malignancy, and therapeutic or diagnostic studies aimed at establishing reliable prognostic indicators for disease progression and/or minimizing morbidity and mortality associated with this malignancy. - Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism types, numbers, qualities, durations, and costs of the applications received. - The types of mechanisms to be supported include traditional investigator-initiated R01 (individual) and R21 (exploratory/developmental) research grant applications. - You may submit (an) application(s) if your organization has any of the following characteristics: for-profit organizations ; non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State governments; units of local governments; eligible agencies of the Federal government; domestic institutions; foreign institutions; and faith-based or community-based organizations. - Eligible principal investigators include a ny individual with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. - Applicants may submit more than one application, provided they are scientifically distinct. - See Section IV.1 for application and submission information. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088.